UniProt ID | LIRA3_HUMAN | |
---|---|---|
UniProt AC | Q8N6C8 | |
Protein Name | Leukocyte immunoglobulin-like receptor subfamily A member 3 | |
Gene Name | LILRA3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 439 | |
Subcellular Localization | Secreted . | |
Protein Description | Acts as soluble receptor for class I MHC antigens. Binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1 or LILRB2. Binds with high affinity to the surface of monocytes, leading to abolish LPS-induced TNF-alpha production by monocytes.. | |
Protein Sequence | MTPILTVLICLGLSLDPRTHVQAGPLPKPTLWAEPGSVITQGSPVTLRCQGSLETQEYHLYREKKTALWITRIPQELVKKGQFPILSITWEHAGRYCCIYGSHTAGLSESSDPLELVVTGAYSKPTLSALPSPVVTSGGNVTIQCDSQVAFDGFILCKEGEDEHPQCLNSHSHARGSSRAIFSVGPVSPSRRWSYRCYGYDSRAPYVWSLPSDLLGLLVPGVSKKPSLSVQPGPVVAPGEKLTFQCGSDAGYDRFVLYKEWGRDFLQRPGRQPQAGLSQANFTLGPVSRSYGGQYTCSGAYNLSSEWSAPSDPLDILITGQIRARPFLSVRPGPTVASGENVTLLCQSQGGMHTFLLTKEGAADSPLRLKSKRQSHKYQAEFPMSPVTSAHAGTYRCYGSLSSNPYLLTHPSDPLELVVSGAAETLSPPQNKSDSKAGE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
89 | Phosphorylation | QFPILSITWEHAGRY CCCEEEEECEECCCE | 22.79 | 18785766 | |
140 | N-linked_Glycosylation | PVVTSGGNVTIQCDS CEEECCCCEEEECCC | 31.14 | 24085305 | |
170 | Phosphorylation | EHPQCLNSHSHARGS CCCCHHHCCCCCCCC | 17.26 | - | |
172 | Phosphorylation | PQCLNSHSHARGSSR CCHHHCCCCCCCCCC | 20.75 | - | |
194 | Phosphorylation | VSPSRRWSYRCYGYD CCCCCCEEEEEECCC | 10.82 | - | |
281 | N-linked_Glycosylation | QAGLSQANFTLGPVS CCCCCCCCEEECCCC | 23.85 | 24085305 | |
302 | N-linked_Glycosylation | YTCSGAYNLSSEWSA EEECCCEECCCCCCC | 32.67 | 24085305 | |
341 | N-linked_Glycosylation | PTVASGENVTLLCQS CEECCCCCEEEEEEC | 35.28 | 24085305 | |
378 | Phosphorylation | SKRQSHKYQAEFPMS CHHHHCCEEEECCCC | 13.92 | - | |
385 | Phosphorylation | YQAEFPMSPVTSAHA EEEECCCCCCCCCCC | 19.22 | - | |
431 | N-linked_Glycosylation | ETLSPPQNKSDSKAG HCCCCCCCCCCCCCC | 52.12 | 24085305 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LIRA3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LIRA3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LIRA3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MYCB2_HUMAN | MYCBP2 | physical | 26186194 | |
SYNC_HUMAN | NARS | physical | 26186194 | |
LIRA1_HUMAN | LILRA1 | physical | 26186194 | |
LIRB1_HUMAN | LILRB1 | physical | 26186194 | |
LIRB1_HUMAN | LILRB1 | physical | 28514442 | |
LIRA1_HUMAN | LILRA1 | physical | 28514442 | |
SYNC_HUMAN | NARS | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...